Clinical Trial Update: A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the completion of a randomized Phase 2/Phase 3 trial evaluating inhaled amphotericin B for maintaining remission in Allergic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Bronchopulmonary Aspergillosis

Drugs mentioned

• Inhaled Amphotericin B (amphotericin B)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 2, Phase 3 | Status: COMPLETED